MedPath

Intraosseous vs. Intravenous Vancomycin Administration in Total Ankle Arthroplasty

Phase 4
Recruiting
Conditions
Infections
Ankle Arthritis
Interventions
Drug: Intravenous Vancomycin
Drug: Intraosseous Vancomycin Injection
Registration Number
NCT06384651
Lead Sponsor
The Methodist Hospital Research Institute
Brief Summary

The purpose of this study is to compare two different antibiotic regimens and techniques during total ankle arthroplasty (TAA).

Primary Objective: Comparable levels of vancomycin will be found in bone, soft tissue, and systemic samples between patient groups.

Secondary Objective: Compare 30 day and 90 day post-operative complication rates (infection) between the control (standard IV administration of vancomycin) vs the interventional group (intraosseous administration of vancomycin). The investigators hypothesize that there will be no difference in complication (infection) rates between groups.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intravenous VancomycinIntravenous VancomycinPatients will receive the orthopedic surgeon's standard of care pre-operative antibiotic regimen for TAA patients. This includes IV antibiotics (typically ancef or cefepime and vancomycin) will be started in the pre-operative period approximately 1 hour prior to incision (vancomycin dose weight-based at approximately 15mg/kg generally 1000-1750mg in 500mL normal saline (NS))
Intraosseous VancomycinIntraosseous Vancomycin InjectionIV antibiotics per physician's standard of care: Typically ancef or cefepime is started in pre-op within 1 hour of incision. IV Vancomycin will not be given preoperatively in this group. IO vancomycin is administered in the OR after sterile prep and draping has occurred (500mg in 100-150mL NS). IO Injection will take place into the medial malleolus.
Primary Outcome Measures
NameTimeMethod
Systemic Sample Vancomycin Tissue Concentration - End of Caseperioperatively
Systemic Sample Vancomycin Tissue Concentration - Start of Caseperioperatively
Capsule or Synovium Sample Vancomycin Tissue Concentrationimmediately after the procedure
Talar Bone Sample Vancomycin Tissue Concentrationimmediately after the procedure
Distal Tibia Sample Vancomycin Tissue Concentrationimmediately after the procedure
Secondary Outcome Measures
NameTimeMethod
90 day post-operative wound complication and infection rates90 days after the procedure

Trial Locations

Locations (1)

Houston Methodist Hospital

🇺🇸

Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath